Physician Views Results: BMS's Sotyktu set to emerge as important new oral option for psoriatic a...

Physician Views Results: BMS's Sotyktu set to emerge as important new oral option for psoriatic arthritis  FirstWord Pharma

Michael Cantrell: Collaboration Across SWOG, BMS, and Partners Drives Filing Milestone - Oncodaily

Michael Cantrell: Collaboration Across SWOG, BMS, and Partners Drives Filing Milestone  Oncodaily

DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream - PharmaTimes

DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream  PharmaTimes

BMS secures FDA and EC approvals for Opdivo in Hodgkin Lymphoma - Pharmaceutical Technology

BMS secures FDA and EC approvals for Opdivo in Hodgkin Lymphoma  Pharmaceutical Technology

Micro-Storage BMS: The Intelligent Core of Future Smart Home Energy Distribution - openPR.com

Micro-Storage BMS: The Intelligent Core of Future Smart Home Energy Distribution  openPR.com

BMS wins dual immunotherapy-first approvals in classical Hodgkin Lymphoma - European Pharmaceutic...

BMS wins dual immunotherapy-first approvals in classical Hodgkin Lymphoma  European Pharmaceutical Review

How BMS Tech Drives Safety, Performance & Asset Longevity - Battery Technology

How BMS Tech Drives Safety, Performance & Asset Longevity  Battery Technology

insitro and BMS collaboration further expanded - The Pharma Letter

insitro and BMS collaboration further expanded  The Pharma Letter

Korean BMS Chip Startup Anabatic Semi Raises $10M Series A Follow-on Round - Wowtale

Korean BMS Chip Startup Anabatic Semi Raises $10M Series A Follow-on Round  Wowtale

BMS builds momentum for CELMoD drug after improving myeloma PFS in phase 3 - Fierce Biotech

BMS builds momentum for CELMoD drug after improving myeloma PFS in phase 3  Fierce Biotech

Insitro and Bristol Myers Squibb expand ALS collaboration - BioWorld MedTech

Insitro and Bristol Myers Squibb expand ALS collaboration  BioWorld MedTech

Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? - Labiotech.eu

Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff?  Labiotech.eu

BMS Band hosts spring concert and awards ceremony - Peak of Ohio

BMS Band hosts spring concert and awards ceremony  Peak of Ohio

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheime...

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026  Business Wire

Talc Company Fails in Attempt to Dismiss Mesothelioma Lawsuit - Mesothelioma.net

Talc Company Fails in Attempt to Dismiss Mesothelioma Lawsuit  Mesothelioma.net

Bristol-Myers Squibb: Dividend/Portfolio Renewal Thesis Remains Promising (NYSE:BMY) - Seeking Alpha

Bristol-Myers Squibb: Dividend/Portfolio Renewal Thesis Remains Promising (NYSE:BMY)  Seeking Alpha

JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff - Clinical Trials Arena

JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff  Clinical Trials Arena

Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb

Science Firsthand: Translating the promise of cell therapy  Bristol Myers Squibb

BMS, insitro add two more targets to AI-powered ALS partnership - FirstWord Pharma

BMS, insitro add two more targets to AI-powered ALS partnership  FirstWord Pharma

Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial - Fierce ...

Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial  Fierce Biotech

BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncolog...

BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists  Fierce Pharma

BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments - BioSpace

BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments  BioSpace

Science Firsthand: Making the leap to intentionally designed degraders - Bristol Myers Squibb

Science Firsthand: Making the leap to intentionally designed degraders  Bristol Myers Squibb

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour  BioSpace

FDA Action Alert: BMS, GSK, Aldeyra and More - BioSpace

FDA Action Alert: BMS, GSK, Aldeyra and More  BioSpace

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...

Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B  Fierce Biotech

Champions in Care - Bristol Myers Squibb

Champions in Care  Bristol Myers Squibb

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)  Bristol Myers Squibb

Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis - Fie...

Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis  Fierce Biotech

BMS Art on Main Keeps Spotlight on Emotions - Eagle Country 99.3

BMS Art on Main Keeps Spotlight on Emotions  Eagle Country 99.3

Automotive Battery Management System (BMS) Market to Grow at 17% - openPR.com

Automotive Battery Management System (BMS) Market to Grow at 17%  openPR.com

BMS Beats Again Despite Eliquis and Cobenfy Disappointments - BioSpace

BMS Beats Again Despite Eliquis and Cobenfy Disappointments  BioSpace

Biopharma bites: Layoffs at BMS, Generate's IPO plans, Fortress's voucher sale…and more - FirstWo...

Biopharma bites: Layoffs at BMS, Generate's IPO plans, Fortress's voucher sale…and more  FirstWord Pharma

Bristol Myers and Evinova pen global development partnership - Fierce Biotech

Bristol Myers and Evinova pen global development partnership  Fierce Biotech

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace

BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line  BioSpace

Driving patient-centric care through global patient outreach - Bristol Myers Squibb

Driving patient-centric care through global patient outreach  Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb

Empowering patients with clarity & confidence through UPL program  Bristol Myers Squibb

Building a healthier future together: Strengthening cancer care across Africa through partnership...

Building a healthier future together: Strengthening cancer care across Africa through partnership  Bristol Myers Squibb

BMS pens $850M solid tumor pact with T-cell engager biotech Janux - Fierce Biotech

BMS pens $850M solid tumor pact with T-cell engager biotech Janux  Fierce Biotech

With declining sales of legacy meds, BMS leans on new growth drivers to weather the storm - Fierc...

With declining sales of legacy meds, BMS leans on new growth drivers to weather the storm  Fierce Pharma

Anabatic Semi, a startup specializing in domestic battery management systems (BMS) semiconductors...

Anabatic Semi, a startup specializing in domestic battery management systems (BMS) semiconductors, a..  매일경제

Patient Advocate Foundation Announces $1 Million Donation from Bristol Myers Squibb Foundation - ...

Patient Advocate Foundation Announces $1 Million Donation from Bristol Myers Squibb Foundation  Patient Advocate Foundation

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA - Fierc...

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA  Fierce Biotech

Chris Shibutani, MD - Bristol Myers Squibb

Chris Shibutani, MD  Bristol Myers Squibb

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace

BMS Makes $1.5B Cell Therapy Play With Orbital Takeover  BioSpace

BMS' Cobenfy TV ad is latest target of FDA untitled letter spree - Fierce Pharma

BMS' Cobenfy TV ad is latest target of FDA untitled letter spree  Fierce Pharma

Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb

Science Firsthand: The renaissance of neuroscience R&D  Bristol Myers Squibb

Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb

Nurse practitioners impact patient care and foster collaboration  Bristol Myers Squibb

Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn - European Pharmaceutical R...

Bristol Myers Squibb acquires cell therapy biotech Orbital for $1.5bn  European Pharmaceutical Review

Bristol Myers Squibb Kidney Cancer Trial Tests Valuation And Pipeline Depth - simplywall.st

Bristol Myers Squibb Kidney Cancer Trial Tests Valuation And Pipeline Depth  simplywall.st

Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing - Fierce Pharma

Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing  Fierce Pharma

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer t...

Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test  Fierce Biotech

Protein homeostasis 101: A Q&A with Mark Rolfe - Bristol Myers Squibb

Protein homeostasis 101: A Q&A with Mark Rolfe  Bristol Myers Squibb

A global journey through BMS’ R&D hubs - Bristol Myers Squibb

A global journey through BMS’ R&D hubs  Bristol Myers Squibb

Stenhouse optimistic about BMS package - Kingsport Times News

Stenhouse optimistic about BMS package  Kingsport Times News

BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” - Clinical Trials Arena

BMS delays Alzheimer’s readout for Cobenfy over “site irregularities”  Clinical Trials Arena

Cytokinetics Wins FDA Approval, Clearing Way to Challenge BMS in Heart Disease Market - BioSpace

Cytokinetics Wins FDA Approval, Clearing Way to Challenge BMS in Heart Disease Market  BioSpace

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026 - Yahoo Finance

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026  Yahoo Finance

New RayzeBio hub accelerates next-gen cancer therapies - Bristol Myers Squibb

New RayzeBio hub accelerates next-gen cancer therapies  Bristol Myers Squibb

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace

BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC  BioSpace

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...

BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future  Fierce Biotech

"Too many patients in rural America face barriers to cardiovascular care — barriers that - Bristo...

"Too many patients in rural America face barriers to cardiovascular care — barriers that  Bristol Myers Squibb

Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s - statnews.com

Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s  statnews.com

BMS sells controlling stake in historic US-China pharmaceutical joint venture - Fierce Pharma

BMS sells controlling stake in historic US-China pharmaceutical joint venture  Fierce Pharma

BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe - JUVE Patent

BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe  JUVE Patent

Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma

Merck & Co., BMS to lay off over 300 staffers in New Jersey  FirstWord Pharma

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...

BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients  Fierce Pharma

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis  Fierce Pharma

BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates...

BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates  BioSpace

WCLC25: BioNTech, BMS tout second readout for PD-L1/VEGF-A in SCLC - FirstWord Pharma

WCLC25: BioNTech, BMS tout second readout for PD-L1/VEGF-A in SCLC  FirstWord Pharma

Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy? - BioSpace

Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy?  BioSpace

Bristol Myers Squibb discloses 247 more layoffs in NJ (updated) - NJBIZ

Bristol Myers Squibb discloses 247 more layoffs in NJ (updated)  NJBIZ

Bristol Myers Squibb paves way for expansion of Camzyos to adolescent patients - Fierce Pharma

Bristol Myers Squibb paves way for expansion of Camzyos to adolescent patients  Fierce Pharma

BMS Teacher of the Year arrested on child sex abuse charges - KATC

BMS Teacher of the Year arrested on child sex abuse charges  KATC

Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal - Fierce Pharma

Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal  Fierce Pharma

How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - Harvard Business Review

How Bristol Myers Squibb Transformed Working Capital to Fund Its Future  Harvard Business Review

New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role - Purd...

New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role  Purdue University College of Veterinary Medicine

BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma

BMS, Bain Capital team up on autoimmune-focused newco  FirstWord Pharma

BMS snags top neuro researcher from Eisai—Chutes & Ladders - Fierce Biotech

BMS snags top neuro researcher from Eisai—Chutes & Ladders  Fierce Biotech

BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant - BioSpace

BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant  BioSpace

FDA Action Alert: BMS, GSK, Amgen and More - BioSpace

FDA Action Alert: BMS, GSK, Amgen and More  BioSpace

Harnessing the Potential of Anti-Cancer Modalities - Bristol Myers Squibb

Harnessing the Potential of Anti-Cancer Modalities  Bristol Myers Squibb

BMS and Microsoft partner for AI-based lung cancer detection - Pharmaceutical Technology

BMS and Microsoft partner for AI-based lung cancer detection  Pharmaceutical Technology

BMS, J&J factor in HCP education on clot-busting mechanism before milvexian data drop - Fierce Ph...

BMS, J&J factor in HCP education on clot-busting mechanism before milvexian data drop  Fierce Pharma

BMS ups guidance, but its financial prospects fail to capture investor enthusiasm - FirstWord Pharma

BMS ups guidance, but its financial prospects fail to capture investor enthusiasm  FirstWord Pharma

BMS boosts cancer trials with Sarah Cannon's clinical research platform - Fierce Biotech

BMS boosts cancer trials with Sarah Cannon's clinical research platform  Fierce Biotech

Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva

Bristol Myers Squibb Commits to Veeva Vault CRM  Veeva

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...

BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia  Fierce Biotech

Karen Costello appointed General Manager of Bristol Myers Squibb Benelux - Bristol Myers Squibb

Karen Costello appointed General Manager of Bristol Myers Squibb Benelux  Bristol Myers Squibb

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 20...

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035  PR Newswire

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...

ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial  Fierce Biotech

Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility - European Pharmaceutical Review

Rovi’s injectables CDMO rebrands as Rois and acquires BMS facility  European Pharmaceutical Review

BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes - Fierce Biotech

BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes  Fierce Biotech

BMS builds a 'world of gratitude' to honor healthcare workers in new PSA - Fierce Pharma

BMS builds a 'world of gratitude' to honor healthcare workers in new PSA  Fierce Pharma

Veterans redefining manufacturing leadership in pharma - Bristol Myers Squibb

Veterans redefining manufacturing leadership in pharma  Bristol Myers Squibb

BMS direct platform adds psoriasis drug Sotyktu with deep price cut - FirstWord Pharma

BMS direct platform adds psoriasis drug Sotyktu with deep price cut  FirstWord Pharma

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace

BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study  BioSpace

JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy - BioSpace

JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy  BioSpace

Workforce Planner: Manage people and projects in BMS - Kaseya

Workforce Planner: Manage people and projects in BMS  Kaseya

C2C4C marks 12 inspiring years advancing cancer research - Bristol Myers Squibb

C2C4C marks 12 inspiring years advancing cancer research  Bristol Myers Squibb